Walleye Trading’s Emergent Biosolutions EBS Stock Holding History

Walleye Trading’s Portfolio EBS Stock Details EBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-1,620	Closed	-$5.51K	–	5160
2023 Q3	$5.51K	Sell	1,620 -4,366	-73%	-$24.2K	﹤0.01%	4621
2023 Q2	$44K	Buy	+5,986	New	+$55.5K	﹤0.01%	3988
2018 Q4	–	Sell	-7,438	Closed	-$490K	–	4791
2018 Q3	$490K	Buy	+7,438	New	+$434K	﹤0.01%	2919
2017 Q2	–	Sell	-13,600	Closed	-$395K	–	4594
2017 Q1	$395K	Buy	13,600 +400	+3%	+$12.2K	﹤0.01%	2441
2016 Q4	$433K	Buy	+13,200	New	+$396K	﹤0.01%	2195
2016 Q3	–	Sell	-24,600	Closed	-$692K	–	4968
2016 Q2	$692K	Buy	24,600 +23,100	+1,540%	+$906K	﹤0.01%	1922
2016 Q1	$55K	Buy	+1,500	New	+$53K	﹤0.01%	3804
2015 Q4	–	Sell	-1,600	Closed	-$46K	–	5364
2015 Q3	$46K	Buy	1,600 +1,500	+1,500%	+$49.4K	﹤0.01%	3566
2015 Q2	$3K	Buy	+100	New	+$3.1K	﹤0.01%	4611

Other funds holding EBS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

OHA

Oak Hill Advisors New York $701M AUM 78.4% 1-Year Est. Return

PCM

Palisade Capital Management Fort Lee, New Jersey $2.3B AUM 29.92% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Walleye Trading's EBS Position: Q4 2023 in Review

Walleye Trading sold out of Emergent Biosolutions (EBS) in Q4 2023, closing a stake of 1,620 shares — an estimated $5.51K sold.

Walleye Trading first reported a position in EBS in Q2 2015 and held it in 9 quarters. The position peaked at $692K in Q2 2016. 134 funds tracked by Wall St. Rank hold EBS as of Q4 2023.

Walleye Trading reported no remaining Emergent Biosolutions position as of Q4 2023 after selling out during the quarter.
Walleye Trading sold 1,620 Emergent Biosolutions shares in Q4 2023, an estimated $5.51K.
Walleye Trading first reported a position in Emergent Biosolutions in Q2 2015 and held it in 9 quarters.
Walleye Trading's Emergent Biosolutions position peaked at $692K in Q2 2016.
134 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q4 2023.

Based on Walleye Trading's 13F filing for Q4 2023, filed 14 Feb 2024.